← Back to Search

Behavioural Intervention

Psychological Therapies for Chronic Pain via Telehealth (GPTVTCOVCP Trial)

N/A
Recruiting
Led By Brandon C Yarns, MD MS BME
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 60-95 years
Have an average daily pain intensity of at least 4 on a 0 to 10 scale
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights

GPTVTCOVCP Trial Summary

This trial is investigating the effectiveness of 3 psychological treatments for chronic pain among older US Veterans, delivered via telehealth. It's assessing the best treatment for them and how it works.

Who is the study for?
This trial is for U.S. military Veterans aged 60-95 with chronic musculoskeletal pain, such as back or neck pain, lasting at least 3 months and causing moderate to severe daily discomfort. Participants must be able to use video telehealth services and speak English fluently.Check my eligibility
What is being tested?
The study compares three psychological treatments delivered via video conference: Cognitive-Behavioral Therapy (CBT), Emotional Awareness and Expression Therapy (EAET), and Mindfulness Meditation (MM). It aims to determine which treatment works best for older Veterans with chronic pain.See study design
What are the potential side effects?
Psychological interventions like CBT, EAET, and MM may cause emotional discomfort or distress initially as individuals confront difficult emotions or thoughts related to their chronic pain.

GPTVTCOVCP Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 60 and 95 years old.
Select...
My daily pain level averages at least 4 out of 10.

GPTVTCOVCP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to 20 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to 20 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Brief Pain Inventory: Mean Pain Severity
Secondary outcome measures
Brief Pain Inventory: Pain Interference
Generalized Anxiety Disorder 2-item
PTSD Checklist for DSM-5
+4 more
Other outcome measures
Chronic Pain Acceptance Questionnaire-2 Item
Coping Strategies Questionnaire
Emotional Approach Coping Scales
+7 more

GPTVTCOVCP Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Mindfulness MeditationExperimental Treatment1 Intervention
Seeks to help individuals achieve present moment awareness, self-compassion, and acceptance of chronic pain. It will use techniques such as the body scan, grounding, mindful breathing, mindful walking, loving kindness, and compassionate breathing.
Group II: Emotional Awareness and Expression TherapyExperimental Treatment1 Intervention
Seeks to reduce physical (e.g., pain) and emotional (e.g., depression, anxiety) symptoms by helping individuals become aware of their emotions, express them, and resolve emotional conflicts. It will use techniques such as writing about stress, role playing how to handle difficult relationships, recognizing and expressing anger and other feelings, and being more open with others.
Group III: Cognitive Behavioral TherapyActive Control1 Intervention
Seeks to help individuals function better and improve symptoms by teaching various cognitive and behavioral skills to manage symptoms. It will use techniques such as relaxation training, engaging in pleasant activities, pacing yourself, and changing unhelpful ways of thinking.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Emotional Awareness and Expression Therapy
2019
N/A
~260
Mindfulness Meditation
2017
Completed Phase 2
~4780

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,611 Previous Clinical Trials
3,305,068 Total Patients Enrolled
6 Trials studying Chronic Musculoskeletal Pain
4,465 Patients Enrolled for Chronic Musculoskeletal Pain
Brandon C Yarns, MD MS BMEPrincipal InvestigatorVA Greater Los Angeles Healthcare System, West Los Angeles, CA
1 Previous Clinical Trials
126 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals above the age of thirty eligible to participate in this study?

"As per the defined conditions for participation, this trial welcomes individuals aged between 60 and 95 years old."

Answered by AI

Is it feasible for me to partake in this clinical experiment?

"Eligible participants for this trial must suffer from chronic musculoskeletal pain, and be aged between 60 and 95. Approximately 216 individuals are being recruited into the study."

Answered by AI

Are enrollment opportunities still open for this research initiative?

"Unfortunately, this clinical trial is no longer taking on participants. As evidenced by the fact that it was first published on October 1st 2023 and last edited August 16th of the same year, there have not been any new enrollments recently. Nevertheless, 448 other studies are still recruiting patients at present."

Answered by AI
~144 spots leftby Sep 2027